Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization 2025-01-03 21:15
GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer 2025-01-03 15:30
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene 2025-01-03 13:30
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044 2025-01-03 01:43
WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year 2025-01-02 17:30
Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers 2025-01-02 17:17
FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections 2025-01-02 12:52
CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy 2024-12-31 21:50
Ractigen Therapeutics Founder Dr. Long-Cheng Li Awarded 2024 Life Science Ice Breaking Award 2024-12-31 20:00
Duality Biologics Announces B7H4 ADC Milestone Achievement and License Exercise by BeiGene 2024-12-31 08:00
I Peace manufactures 100 lines of GMP iPS Cells cumulatively 2024-12-31 04:24
Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference 2024-12-30 23:00
CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel) 2024-12-30 21:50
WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year 2024-12-30 20:00
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting 2024-12-25 15:42
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS 2024-12-24 20:00
Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis 2024-12-23 22:31
Porton Pharma Solutions and Dragon Sail Pharmaceutical Form Strategic Partnership to Build a New Ecosystem for ADC Drug Development, Production, and Supply Chain 2024-12-23 21:00
United Imaging Intelligence at RSNA 2024: Empowering a More Intelligent and Connected World with Medical AI 2024-12-20 22:00
Medicilon Appoints Dr. Lilly Xu as Chief Technology Officer 2024-12-20 21:30
1 2 3 4 5 226